Key result
Plasma cardiac-specific E3 ligase Rnf207 increased at 1 h, peaked at 3 h, and showed similar diagnostic sensitivity and specificity to cardiac troponin I for acute myocardial infarction.
Observational
Answers are grounded in this paper and cite their sources.
Ubiquitin ligase (E3) is a decisive element of the ubiquitin-proteasome system (UPS), which is the main pathway for intracellular protein turnover. Recently, circulating E3 ligases have been increasingly considered as cancer biomarkers. In the present study, we aimed to determine if cardiac-specific E3 ligases in circulation can serve as novel predictors for early diagnosis of acute myocardial infarction (AMI). By screening and verifying their tissue expression patterns with microarray and real-time PCR analysis, six of 261 E3 ligases, including cardiac-specific Rnf207 and cardiac- and muscle-enriched Fbxo32/atrogin-1, Trim54/MuRF3, Trim63/MuRF1, Kbtbd10/KLHL41, Asb11 and Asb2 in mouse heart, were selected for the present study. In the AMI rats, the levels of five E3 ligases including Rnf207, Fbxo32, Trim54, Trim63 and Kbtbd10 in the plasma were significantly increased compared with control animals. Especially, the plasma levels of Rnf207 was markedly increased at 1 h, peaked at 3 h and decreased at 6-24 h after ligation. Further evaluation of E3 ligases in AMI patients confirmed that plasma Rnf207 level increased significantly compared with that in healthy people and patients without AMI, and showed a similar time course to that in AMI rats. Simultaneously, plasma level of cardiac troponin I (cTnI) was measured by ELISA assays. Finally, receiver operating characteristic (ROC) curve analysis indicated that Rnf207 showed a similar sensitivity and specificity to the classic biomarker troponin I for diagnosis of AMI. Increased cardiac-specific E3 ligase Rnf207 in plasma may be a novel and sensitive biomarkers for AMI in humans.
No takes yet. Share an insight, caveat, or question.
Han et al. (2015) conducted an observational in Acute myocardial infarction (AMI). Circulating cardiac-specific E3 ligases (specifically Rnf207) vs. Cardiac troponin I (cTnI), healthy controls, and non-AMI patients was evaluated on Diagnostic sensitivity and specificity for acute myocardial infarction. Plasma cardiac-specific E3 ligase Rnf207 increased at 1 h, peaked at 3 h, and showed similar diagnostic sensitivity and specificity to cardiac troponin I for acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: